For the first time, we demonstrated that, in human platelets from T2DM subjects, not only protease-activated receptor 4 (PAR-4) promotes the release of activated PMP through a Ca2+-calpain dependent mechanism, but also that its expression is upregulated by chronic hyperglycemia. This evidence concerns the gene F2RL3 and type 2 diabetes mellitus.